Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine

Sponsor
Paris Translational Research Center for Organ Transplantation
Study ID
NCT07600541
Status
Recruiting
Apply to this trial

Conditions

  • Kidney Transplant

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The AITX study is an international, multicenter survey exploring how kidney transplant recipients perceive artificial intelligence (AI) in medicine and, specifically, a system that predicts graft loss risk. Through an open-ended online questionnaire distributed across transplant centers and patient associations in France and the United States, the study captures patients' expectations, concerns, and the perceived impact of AI-driven prediction on their daily lives. Responses are analyzed using large language models (LLMs) with systematic human verification. The study aims to ensure that the deployment of AI in transplantation is ethical, transparent, and patient-centered.

Key Dates

First listed
May 20, 2026
Start date
Apr 15, 2026
Status verified
May 2026
Primary completion
Sep 30, 2026
Completion
Dec 30, 2026

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Vita move
    Association of transplant recipients
  • Arm: France rein pays de la loire
    Association of patients with kidney disease
  • Arm: France rein île de france
    Association of patients with kidney disease
  • Arm: France rein nord pas de calais
    Association of patients with kidney disease
  • Arm: Saint-Louis hospital
    Hospital
  • Arm: Nice Pasteur
    Hospital
  • Arm: Marseille hospital
    hospital
  • Arm: Lille
    hospital
  • Arm: The voice of the patient
    Association of patients with kidney disease
  • Arm: Utah university
    hospital
  • Arm: Mayo Clinic jacksonville
    hospital

Primary Outcome Measure

Perceptions of patients about AI [ Time Frame: Baseline (corresponding to questionnaire administration) ]

Related Studies